Ayumi Fujimoto Selected Research

Ayumi Fujimoto Research Topics

8	Neoplasms (Cancer) 01/2024 - 01/2013
7	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 10/2018
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2024 - 01/2019
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 11/2021
3	Deafness (Deaf Mutism) 12/2019 - 01/2015
2	Aplastic Anemia (Anemia, Hypoplastic) 02/2024 - 01/2019
2	Lymphoma (Lymphomas) 01/2021 - 04/2020
2	Large Granular Lymphocytic Leukemia 01/2021 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2018
2	Hearing Loss (Hearing Impairment) 12/2019 - 12/2016
1	Carcinoma (Carcinomatosis) 01/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023
1	Bronchiolitis Obliterans Syndrome 11/2023
1	Hematuria 11/2023
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 01/2022
1	Tertiary Lymphoid Structures 11/2021
1	Pain (Aches) 05/2020
1	Stomach Neoplasms (Stomach Cancer) 05/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2020
1	Infections 04/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019
1	Plasma Cell Leukemia 01/2019
1	Plasma Cell Neoplasms 01/2019
1	Sensorineural Hearing Loss 12/2016
1	Pruritus (Itching) 05/2016
1	Atopic Dermatitis (Atopic Eczema) 05/2016
1	Liver Diseases (Liver Disease) 07/2013
1	Hepatitis 07/2013
1	Hepatocellular Carcinoma (Hepatoma) 01/2013
1	Heart Failure 10/2009
1	Cough 10/2009
1	Dyspnea (Shortness of Breath) 10/2009
1	Cardiomyopathies (Cardiomyopathy) 10/2009

3	Connexin 26IBA 12/2019 - 01/2015
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 02/2024 - 01/2019
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 10/2018
1	cabazitaxel FDA Link 01/2024
1	Large Neutral Amino Acid-Transporter 1IBA 01/2024
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2024
1	2- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acidIBA 01/2024
1	Essential Amino AcidsIBA 01/2024
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2024
1	lenvatinibIBA 05/2023
1	pembrolizumabIBA 05/2023
1	Tyrosine Kinase InhibitorsIBA 05/2023
1	ruxolitinibIBA 01/2022
1	IpilimumabIBA 11/2021
1	NivolumabIBA 11/2021
1	Immune Checkpoint InhibitorsIBA 11/2021
1	AndrogensIBA 09/2021
1	CatecholaminesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Fusion Regulatory Protein-1IBA 01/2021
1	TegafurIBA 05/2020
1	gimeracilIBA 05/2020
1	Oxonic AcidIBA 05/2020
1	Rituximab (Mabthera)FDA Link 04/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	Testosterone (Sustanon)FDA Link 01/2020
1	Lenalidomide (CC 5013)FDA Link 01/2019
1	Pregnenolone Carbonitrile (PCN)IBA 01/2019
1	SteroidsIBA 10/2018
1	abirateroneIBA 10/2018
1	5'-N-methylcarboxamideadenosineIBA 05/2016
1	ConnexinsIBA 01/2015
1	Carbon Tetrachloride (Tetrachloromethane)IBA 07/2013
1	Surface Antigens (Surface Antigen)IBA 01/2013
1	Anesthetics (Anesthetic Agents)IBA 10/2009
1	Furosemide (Lasix)FDA LinkGeneric 10/2009

7	Therapeutics 05/2023 - 07/2013
4	Stem Cell Transplantation 01/2021 - 04/2020
3	Castration 01/2024 - 10/2018
3	Prostatectomy (Retropubic Prostatectomy) 12/2023 - 11/2022
3	Nephrectomy 11/2023 - 11/2021
3	Hematopoietic Stem Cell Transplantation 04/2020 - 01/2019
2	Transplantation 11/2023 - 01/2019
1	Cell Transplantation 02/2024
1	Lung Transplantation 11/2023
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2023
1	Renal Dialysis (Hemodialysis) 11/2023
1	Lymph Node Excision (Lymph Node Dissection) 11/2021
1	Drug Therapy (Chemotherapy) 05/2020
1	Gastrectomy 05/2020
1	Organ Transplantation 02/2020
1	Cesarean Section (Caesarean Section) 10/2009